https://techcrunch.com/2023/06/01/enzo-biochem-says-ransomware-attack-exposed-clinical-test-data-of-2-5-million-patients/

Enzo Biochem, a New York-based biotechnology company, has confirmed that a ransomware attack exposed the clinical test information of almost 2.5 million patients.

Enzo, which manufactures and sells DNA-based tests to detect viral and bacterial diseases including COVID-19 and cancer, confirmed in an SEC filing this week that it experienced a ransomware attack on April 6. While it was able to remain operational by disconnecting its systems from the internet, Enzo said it discovered on April 11 that hackers were able to access and exfiltrate sensitive data from the company’s systems.